No Data
No Data
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Analysts Are More Bearish Than They Used To Be
Express News | Baird Maintains Neutral on Mersana Therapeutics, Lowers Price Target to $3
Mersana Therapeutics Analyst Ratings
BTIG Initiates Mersana Therapeutics(MRSN.US) With Buy Rating, Announces Target Price $6
Truist Financial Maintains Mersana Therapeutics(MRSN.US) With Buy Rating
No Data